Interleukin 5 signals through Shc and Grb2 in human eosinophils

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 1, 1998, Pages 75-83

  Bates, Mary Ellen ^a,b   Busse, William W ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b H6 355 CSC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INTERLEUKIN 5; PHOSPHOTYROSINE; PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; EOSINOPHILS; GRB2 ADAPTOR PROTEIN; HUMANS; IMMUNOSORBENT TECHNIQUES; INTERLEUKIN-5; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0031605365     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.1.2766     Document Type: Article

References (65)

1. Bradley, B. L., M. Azzawi, M. Jacobson, B. Assoufi, J. V. Collins, A. M. A. Irani, L. B. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1997. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin, Immunol. 88:661-674.
2. Virehow, J. C., A. Oehling, L., Boer, T. T. Hansel, P. Werner, H. Matthys, K. Blaser, and C. Walker. 1994. Pulmonary function, activated T cells peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: a longitudinal study in bronchial asthma. J. Allergy Clin, Immunol 94: 240-244.
3. Flavahan, N. A., N. R. Silfman, G. J. Gleich, and P. M. Vanhoutte. 1988. Human eosinophils derived major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am. Rev. Respir. Dis. 138:685-688.
4. Rabe, K. F., N. M. Munoz. A. J. Vita, B. E. Morton, H. Magnussen, and A. R. Leff. 1994. Contraction of human bronchial smooth muscle caused by activated human eosinophils. Am. J. Physiol. 267:L326-L334.
5. Ohnishi, T., S. Sur, D. S. Collins, J. E. Fish, G. J. Gleich, and S. P. Peters. 1993. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J. Allergy Clin. Immunol. 92:607-615.
6. Ohnishi, T., H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun, W. W. Busse, J. S. Abrams, and G. J. Gleich. 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901-907.
7. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young, 1996. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
8. Clutterbuck, E. J., E. M. Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3. IL-6. and GMCSF. Blood 73:1504-1512.
9. Sonoda, Y., N. Arai, and M. Ogawa. 1989. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/ macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia 3:14-18.
10. Tominaga, A., S. Takaki, N. Koyama, S. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi, Y. Kanai, J. Miyazaki, G. Usuku, K. Yamamura, and K. Takatsu. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429-137.
11. Neeley, S. P., K. J. Hamann, S. R. White, S. I., Baranowski, R. A. Burch, and A. R. Leff. 1993. Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils. Am. J. Respir. Cell Mol. Biol. 8:633-639.
12. Walsh, G. M., A. Hartnell, A. J. Wardlaw, K. Kurihara, C. J. Sanderson, and A. B. Kay. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunology 71:258-265.
13. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
14. Hartnell, A., D. S. Robinson, A. B. Kay, and A. J. Wardlaw. 1993. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines, Immunology 80:281-286.
15. Coeffier, E., D. Joseph, and B. B. Vargaftig. 1994. Modulation of the enhanced migration of eosinophils from the airways of sensitized guinea pigs: role of IL-5. Ann. N. Y. Acad. Sci. 725:274-281.
16. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R. P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines: III. Effect of the chemokine RANTES. J. Immunol. 153:2153-2160.
17. Carlson, M., C. Peterson, and P. Venge. 1993. The influence of IL-3. IL-5. and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy 48:437-442.
18. Kita, H., D. A. Weiler, R. Abu-Ghazaleh, C. J. Sanderson, and G. J. Gleich. 1992. Release of granule proteins from eosinophils cultured with IL-5. J. Immunol. 149:629-635.
19. 2+ independent and accompanied by induction of tyrosine kinase activity. J. Leuk. Biol. 53:347-353.
20. Van Oosterhout, A. J. M., A. Van Der Poel, L. Koenderman, D. Roos, and F. P. Nijkamp. 1994. Interleukin-5 potentiates sulfidopeptide leukotriene production by human eosinophils. Mediators Inflammation 3:53-55.
21. Takafuji, S., S. C. Bischoff, A. L. De Week, and C. A. Dahinden. 1991. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J. Immunol. 147:3855-3861.
22. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543-3549.
23. Murata, Y., S. Takaki, M. Migita, Y. Kikuchi, A. Tominaga, and K. Takatsu. 1992. Molecular cloning and expression of the human interleukin 5 receptor. J. Exp. Med. 175:341-351.
24. Migita, M., N. Yamaguchi, S. Mita, S. Higuchi, Y. Hitoshi, Y. Yoshida, M. Tomonaga, I. Matsuda, A. Tominaga, and K. Takatsu. 1991. Characterization of the human IL-5 receptors on eosinophils. Cell, Immunol. 133:484-497.
25. Lopez, A. F., M. A. Vadas, J. M. Woodcock, S. E. Milton, A. Lewis, M. J. Elliott, D. Gillis, R. Ireland, E. Olwell, and L. S. Park. 1991. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J. Biol. Chem. 266:24741-24747.
26. Ingley, E., and I. G. Young. 1991. Characterization of a receptor for interleukin-5 on human eosinophils and the myeloid leukemia line HL-60. Blood 78:339-344.
27. van der Bruggen, T., E. Caldenhoven, D. Kanters, P. Coffer, J. A. M. Raaijmakers, J. W. J. Lammers, and L. Koenderman. 1995. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and STAT1 alpha. Blood 85:1442-1448.
28. Pazdrak, K., D. Schreiber, P. Forsythe, L. Justement, and R. Alam. 1995. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J. Exp. Med. 181:1827-1834.
29. Pazdrak, K., S. Stafford, and R. Alam. 1995. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J. Immunol. 155:397-402.
30. Bates, M. E., P. J. Bertics, and W. W. Busse. 1996. IL-5 activates a 45-kilo-dalton mitogen-activated protein kinase and Jak-2 tyrosine kinase in human eosinophils. J. Immunol. 156:711-718.
31. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins (Review). Science 264:1415-1421.
32. Silvennoinen, O., B. A. Witthuhn, F. W. Quelle, J. L. Cleveland, T. Yi. and J. N. Ihle. 1993. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc. Natl. Acad. Sci. USA 90: 8429-8433.
33. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
34. VanderKuur, J., G. Allevato, N. Billestrup, G. Norstedt, and C. Carter-Su. 1995. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem. 270:7587-7593.
35. Nagai, K., M. Takata, H. Yamamura, and T. Kurosaki. 1995. Tyrosine phosphorylation of She is mediated through Lyn and Syk in B cell receptor signaling. J. Biol. Chem. 270:6824-6829.
36. Ptasznik, A., A. Traynor-Kaplan, and G. M. Bokoch. 1995. G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase: She adapter protein signaling complexes. J. Biol. Chem. 270:19969-19973.
37. Thomas, D., S. D. Patterson, and R. A. Bradshaw. 1995. Src homologous and collagen (She) protein binds to F-actin and translocates to the cytoskeleton upon nerve growth factor stimulation in PC12 cells. J. Biol. Chem. 270:28924-28931.
38. Prigent, S. A., T. S. Pillay, K. S. Ravichandran, and W. J. Gullick. 1995. Binding of She to the NPXY motif is mediated by its N-terminal domain. J. Biol. Chem. 270:22097-22100.
39. Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Sehlessinger, and T. Pawson. 1992. Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinase. Nature (London) 360:689-692.
40. Buday, L., and J. Downward. 1993. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611-620.
41. Rozakis-Adcock, M., R. Fernley, J. Wade, T. Pawson, and D. Bowtell, 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 (see comments), Nature (London) 363:83-85.
42. Li, N., A. Batzer, R. Daly, V. Yajnik, E. Skolnik, P. Chardin, D. Bar-Sagi, B. Margolis, and J. Schlessinger. 1993. Guanine-nucleotide-releasing factor hSos1 hinds to Grb2 and links receptor tyrosine kinases to Ras signaling (see comments). Nature (London) 363:85-88.
43. Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis. 1992. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase. Raf-1. and RSK. Cell 68:1041-1050.
44. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 277:680-685.
45. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
46. Welham, M. J., V. Duronio, K. B. Leslie, D. Bowtell, and J. W. Schrader. 1994. Multiple hemopoietins, with the exception of interleukin-4, induce modification of She and mSOS-1. but not their translocation. J. Biol. Chem, 269:21165-21176.
47. Benjamin, C. W., D. A. Linseman, and D. A. Jones. 1994. Platelet-derived growth factor stimulates phosphorylation of growth factor receptor-binding protein-2 in vascular smooth muscle cells. J. Biol. Chem. 269:31346-31349.
48. Isakoff, S. J., Y. P. Yu, Y. C. Su, P. Blaikie, V. Yajnik, E. Rose, K. M. Weidner, M. Sachs, B. Margolis, and E. Y. Skolnik. 1996. Interaction between the phosphotyrosine binding domain of She and the insulin receptor is required for She phosphorylation by insulin in vivo. J. Biol. Chem. 271: 3959-3962.
49. Evans, G. A., M. A. Goldsmith, J. A. Johnston, W. Xu, S. R. Weiler, R. Erwin, O. M. Z. Howard, R. T. Abraham, J. J. O'Shea, W. C. Greene, and W. L. Farrar. 1995. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. J. Biol. Chem. 270:28858-28863.
50. Gronowski, A. M., and P. J. Bertics. 1993. Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors. Endocrinology 133:2838-2846.
51. Okada, S., K. Yamauchi, and J. E. Pessin. 1995. She isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors. J. Biol. Chem. 270:20737-20741.
52. He, T. C., N. Jiang, H. Zhuang, and D. M. Wojchowski. 1995. Erythropoietin-induced recruitment of She via a receptor phosphotyrosine-independent. Jak2-associated pathway. J. Biol. Chem. 270:11055-11061.
53. Owen-Lynch, P. J., A. K. Wong, and A. D. Whetton. 1995. v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J. Biol. Chem. 270:5956-5962.
54. Sakai, I., L. Nabell, and A. S. Kraft. 1995. Signal transduction by a CD16/ CD7/Jak2 fusion protein. J. Biol. Chem. 270:18420-18427.
55. Satoh, T., M. Nakafuku, and Y. Kaziro. 1992. Function of Ras as a molecular switch in signal transduction (Review). J. Biol. Chem. 267:24149-24152.
56. Ravichandran, K. S., U. Lorenz, S. E. Shoelson, and S. J. Burakoff. 1995. Interaction of She with Grb2 regulates association of Grb2 with mSOS. Mol. Cell Biol. 15:593-600.
57. Lanfrancone, L., G. Pelicci, M. F. Brizzi, M. G. Arouica, C. Casciari, S. Giuli, L. Pegoraro, T. Pawson, and P. G. Pelicci. 1995. Overexpression of She proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit. Oncogene 10:907-917.
58. Cutler, R. L., L. Liu, J. E. Damen, and G. Krystal. 1993. Multiple cytokines induce the tyrosine phosphorylation of She and its association with Grb2 in hemopoietic cells. J. Biol. Chem. 268:21463-21465.
59. Liu, L., J. E. Damen, R. L. Cutler, and G. Krystal. 1994. Multiple cytokines stimulate the binding of a common 145-kilodalton protein to She at the Grb2 recognition site of She. Mol. Cell. Biol. 14:6926-6935.
60. Sato, S., T. Katagiri, S. Takaki, Y. Kikuchi, Y. Hitoshi, S. Yonehara, S. Tsukada, D. Kitamura, T. Watanabe, O. Witte, and K. Takatsu. 1994. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J. Exp. Med. 180:2101-2111.
61. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-jun mediated by MAP kinases. Nature (London) 353:670-674.
62. Charest, D. L., G. Mordret, K. W. Harder, F. Jirik, and S. L. Pelech, 1993. Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1. Mol. Cell. Biol. 13:4679-4690.
63. Lin, L. L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278.
64. Harrison-Findik, D., M. Susa, and L. Varticovski. 1995. Association of phosphatidylinositol 3-kinase with She in chronic myelogenous leukemia cells. Oncogene 10:1385-1391.
65. Durstin, M., R. C. Inhorn, and J. D. Griffin. 1996. Tyrosine phosphorylation of She is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines. J. Immunol. 157:534-540.